FIELD: medicine.
SUBSTANCE: invention relates to diagnostic research methods. Method involves determination of the level of glycosaminoglycans and uronic acids in newborn cord blood serum and in their values 225.1-286.1 mcmole/l and 282.0-518.6 mcmole/l, respectively, a baby is considered to be infected. In the level of glycosaminoglycans less 225.1 mcmole/l and the level of uronic acids less 282.0 mcmole/l a baby is considered to be ill. Method is simple for accomplishment, available under clinical conditions and shows the information content on the stage of preclinical diagnosis.
EFFECT: improved diagnosis method.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF MANIFESTATION OF FOETAL HERPES VIRAL INFECTION IN NEWBORNS | 2011 |
|
RU2477484C1 |
| METHOD FOR EARLY DIAGNOSIS OF SEVERE INFECTION CAUSED BY TYPE 6 HERPES VIRUS IN NEWBORNS | 2020 |
|
RU2741864C1 |
| METHOD FOR PREDICTING THE CASES OF INTRAUTERINE FETUS INFECTION WITH EPSTEIN-BARR VIRUS | 2004 |
|
RU2276363C2 |
| METHOD FOR DIAGNOSING INTRAUTERINE VIRAL INFECTION IN BABIES | 2006 |
|
RU2310851C1 |
| METHOD FOR PREDICTION RISK OF TRANSPLACENTAL INFECTION OF NEWBORN | 2013 |
|
RU2518541C1 |
| METHOD FOR PREDICTING RISK OF INTRAUTERINE INFECTION DEVELOPMENT IN NEWBORNS | 2000 |
|
RU2168946C1 |
| METHOD FOR SETTING EARLY STAGE CYTOMEGALOVIRUS INFECTION DIAGNOSIS IN NEWBORNS | 2006 |
|
RU2317550C1 |
| METHOD FOR FEMALE SCREENING FOR PRENATAL DIAGNOSIS OF CONGENITAL ANOMALIES AND INTRAUTERINE INFECTION OF FOETUS | 2011 |
|
RU2461006C1 |
| DIAGNOSTIC TECHNIQUE FOR CONGENITAL VIRAL FOETAL DISEASE | 2019 |
|
RU2728925C1 |
| IMMUNOLOGICAL METHOD FOR EVALUATING NEWBORN BABIES ADAPTATION | 1999 |
|
RU2152619C1 |
